However, there are reports of other drugs impacting on tumour vasculature in combination with RT (such as inhibitors of HIF‐1 and VEGF) that have demonstrated increased anti‐tumour efficacy when administered after RT (Zips et al, 2003; Williams et al, 2004; Harada et al, 2009). The gene discussed is VEGFA; the disease is neoplasm.